Your company shouldn't be upgrading to trendy technology without a strategic purpose, writes this local expert. Photo via Getty Images

In any industry, the use of innovative technologies is often linked to an innovative company. With immersive technologies — including augmented reality, virtual reality, and interactive — heading into the mainstream thanks to COVID-19, brands are now able to reach their audiences in ways like never before. However, instead of incorporating these new technologies into their overall strategy, brands often fall into the trap of using the technology as their only strategy.

When brands are presented with a new and exciting way to interact with consumers in a world where it is hard to maintain their audiences' attention, it's easy to see why this happens. While these brands might get audiences' attention at the beginning when the technology is still novel, the campaign itself most likely won't make a lasting impression, especially as these technologies come more into the mainstream. Additionally, the new and shiny tactic may not be what best serves a brand's ultimate goal.

Starting with strategy

While the use of immersive technologies is growing, it is important to determine whether it is the right solution for the company.

To start, businesses should evaluate their target demographics and goals before investing in new technologies such as virtual reality, augmented reality or animation. When taking all possible stakeholders into account, it will then be easier to shape the experience for maximum engagement and connection with target audiences. For example, in our work at VISION, we once worked with a client whose CEO had told their marketing team that they wanted Google Glass AR for a tradeshow.

The marketing team said they wanted to create an immersive experience and invite existing customers and potential new customers to a private experience using this innovative new technology. However, they did not have a plan for what the experience would be or why the customers were experiencing it. They just wanted to use word of mouth to talk about how cool it was.

Our team came in and listened to the event goals, gave our recommendations, and the client then realized they needed to determine who the customer was and what they wanted to say to the customer from a sales perspective.

That same client came back with a strategy behind the tradeshow experience and ultimately realized they actually did not want an AR experience, but that they wanted a complete immersive experience. From there, this client instead chose a 3D Interactive experience that they could deliver virtually online directly to their clients, and they didn't even use it for the tradeshow. It turned out to be the most successful sales tool they had ever produced.

What tech can do for strategy

Once brands have a broader idea for their strategy and marketing goals, they also need to understand what new immersive technologies are used to accomplish. Beyond creating "buzz," how does each technology actually drive the customer experience and end action desired?

Interactive media—Interactive media is a method of communication in which a program's outputs depend on the user's inputs, and the user's inputs, in turn, affect the program's outputs. Interactive media allows brands to connect with their audiences and making them active participants in the media they consume. Examples include digital graphics, interactive video or in-person touch screen activations.

There are a lot of different forms of interactive media, but at the heart, the goal of this tactic is to create something personalized to the user and establish a memorable connection.

Consider that people remember very little of what they read. They are likely to remember more if they view it in a video format – but they are most likely to remember something they have had a role in themselves. This makes it a particularly compelling technology if the ultimate goal is around education or awareness of a new topic.

Augmented reality – Augmented reality is the overlaying of digitally-created content on top of the real world. AR allows the user to interact with both the real world and digital elements or augmentations. AR can be offered to users via headsets like Microsoft's HoloLens, or through the video camera of a smartphone.

In both practical and experimental implementations, augmented reality can also replace or diminish the user's perception of reality. This altered perception could include simulation of an ocular condition for medical training purposes, or gradual obstruction of reality to introduce a game world. It is worth noting that there is a point when augmented reality and virtual reality likely merge, or overlap. See also, mixed reality.

Particularly in a post-COVID world, AR's applications can meet goals such as facilitating a try-on experience that can lead to direct sales or telling a brand story without the need for an in-person activation or event. We're also seeing AR being used to replace the exhibitor experiences at would-be in-person events, where AR allows the demonstration to come to the user. Now with social distancing mandates restricting in-person presentations, AR is proving even more valuable than ever before as more people begin to see the practical values beyond entertainment.

Virtual reality A high level of VR immersion is achieved by engaging your two most prominent senses, vision and hearing, by using a VR headset and headphones. The VR headset wraps the virtual world or experience nearly to the edge of your natural vision field of view. When you look around, you experience the environment the same as you do when you look around in real life. Headphones amplify the experience by blocking the noise around you, while allowing you to hear the sounds within the VR experience. When you move your head, the sounds within the VR environment move around you like they would in real life. The user becomes immersed within the virtual environment and whilst there, is able to manipulate objects or perform a series of actions.

Virtual Reality has some great applications for training, particularly in healthcare fields or for active shooter preparation. In marketing, companies are implementing VR to enable the consumer to interact with products without having it in their hands — this is particularly applicable for selling luxury properties or furniture that consumers like to touch and feel prior to purchase.

The caveat with virtual reality is consumers cannot typically access this reality without VR goggles, and it is not conducive for a shareable experience that the audience can relive. So, particularly with this tactic, it's crucial to make sure that the "wow-factor" isn't the only goal.

As with anything, knowing what you want to achieve paves the way to get there. Each campaign should start off with establishing the goals. Once companies know what success looks like, they can then utilize creative and effective audience engagement strategies to reach these goals with presentation technology that helps get there.

Every single project is unique and custom. It's impossible to say that one tactic is right for a specific goal. There are ways to think about technology when it comes to those tactics. While a product launch may be great for AR, a real environment visualization is great for VR, or that a multi-user experience is a great way to utilize a permanent interactive display. But the truth is that if you have great strategy and you engage with a great content provider, who truly knows how to develop any type of content, they will be able to guide you in the execution of that tactic and the right technology to support your needs.

------

Dan Pratt is the creative director at Houston-based Vision Production Group.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”

Houston business mogul Tilman Fertitta acquires Caesars in $17.6B deal

Money Moves

Houston billionaire Tilman Fertitta may currently be serving as America’s ambassador to Italy, but his company is as busy as ever. Fresh off its move to revive the Houston Comets WNBA franchise, his company, Fertitta Entertainment, has announced a $17.6 billion deal to acquire Caesars Entertainment, Inc.

Speculation about the deal has been circulating since at least March, according to various media reports. The deal combines Fertitta’s well-known Golden Nugget casino brand with all of the properties in the Caesars’ portfolio, including Las Vegas hotels Caesars Palace, Harrah's, Paris Las Vegas, Planet Hollywood, Horseshoe, The LINQ Hotel, Flamingo, and The Cromwell.

Overall, the combined company will include 60 domestic casino resorts and gaming facilities; online gaming including sports betting, iCasino, and Caesar’s online poker platform; retail sports betting at over 200 third-party locations through the William Hill brand; and over 550 Fertitta Entertainment outlets, including more than 450 Landry's full-service restaurants across America. The companies will combine their loyalty programs, Caesars Rewards, Golden Nugget's 24 Karat Select Club, and Landry's Select Club.

The terms will see Caesars’ shareholders receive $31 per share. Fertitta Entertainment will also acquire approximately $11.9 billion of Caesars' outstanding debt.

The transaction will be financed through a combination of equity contributed by Fertitta Entertainment, assumed Caesars' debt, and new committed debt financing arranged by a group consisting of 10 banks. It is subject to approval by Caesars’ shareholders and government regulators.

Fertitta Entertainment is the Houston-based company behind a diverse array of hospitality businesses, including The Golden Nugget, The Post Oak Hotel, River Oaks District, the Kemah Boardwalk, and Houston’s Downtown Aquarium.

It also operates a number of prominent restaurant brands, including Mastro's Restaurants, Del Frisco's Double Eagle Steakhouse, Morton's The Steakhouse, The Palm, McCormick & Schmick's, Landry's Seafood House, The Oceanaire Seafood Room, and Saltgrass Steak House.

---

This article first appeared on CultureMap.com.

4 Houston-area institutions get $8M for cancer research facilities

fighting cancer

Cancer research capabilities in the Houston area just got an $8 million boost.

On Wednesday, May 20, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded $8 million in grants to institutions in Houston and Bryan for the creation or expansion of so-called “core” cancer research facilities.

“Core facilities provide shared access to advanced technology, equipment, and scientific expertise that may not be available at every institution,” CPRIT says. “These core facilities are vital to not only cancer research but also to the study of diseases beyond cancer.”

Houston-area recipients of these $2 million grants are:

  • A facility at the University of Texas Health Science Center for preclinical support of cancer researchers in Texas to evaluate new safe, effective drugs and drug combinations.
  • The Accelerator for Cancer Therapeutics, operated by Houston’s Texas Medical Center Foundation. The accelerator helps researchers and startups move innovative cancer treatments from the lab to clinical trials.
  • Rice University’s Genetic Design & Engineering Center in Houston. The center enables researchers to collaborate on studies of custom DNA for cancer treatment.
  • A facility at the Texas A&M University System’s Health Science Center in Bryan that aims to speed up the development of cancer therapies.

In addition to those grants, the University of Texas M.D. Anderson Cancer Center, Methodist Hospital Research Institute, Baylor College of Medicine, and Rice University shared $21 million to recruit cancer researchers from other institutions.

The largest of those grants—totalling $4 million—went to M.D. Anderson for the recruitment of renowned cancer researcher Andre Nussenzweig from the National Institutes of Health. His research focuses on how DNA damage and faulty DNA repairs lead to cancer.

Here are the totals for the other CPRIT grants awarded in the Houston area:

  • $12.8 million to Houston-based Indapta Therapeutics for the development of an off-the-shelf therapy that naturally kills cancer cells, combined with an immunity-targeting agent for a type of leukemia.
  • $11.1 million to MD Anderson, including $5 million for a statewide platform to improve long-term health outcomes in adolescents and young adults who survived cancer.
  • $8.4 million to Baylor College of Medicine, including $4.8 million for two training programs for cancer researchers.
  • $6.25 million to UT Health Houston, including $4 million for a biomedical informatics and genomics training program for cancer researchers.
  • $4.4 million to the Texas A&M Health Science Center’s Houston campus, including $2.4 million for a cancer therapeutics training program.
  • $2.75 million to Rice, including $250,000 for a study of ovarian cancer.
  • $2 million to Houston-based March Biosciences for the development of a targeted therapy for treating T-cell lymphoma.
  • $1.15 million to the University of Houston, including $900,000 for a platform for detection of lung cancer.
  • $900,000 to Texas A&M in Bryan to conduct clinical drug trials in rural and underserved communities around the state.
  • $800,000 to Houston- and Israel-based Xerient Pharma for the development of an oral form of a cell-protecting drug called amifostine to protect the upper GI tract from radiation damage during pancreatic cancer treatment.
  • $659,000 to Missouri City-based OmniNano Pharmaceuticals for the development of a two-drug combination to treat the most common form of pancreatic cancer.
  • $250,000 to the University of Texas Medical Branch at Galveston for a novel therapeutic to prevent colitis-related colorectal cancer.